Pediatric Blood & Cancer · 2013 · 59 citations · 12 references
MedicineOncologySurgeryImmunotherapyOncologic SurgerySurgical OncologyMalignant Oral TumorsTongue Cancer Surgery
Lymphangiomas of the tongue are rare, and their treatment is problematic. A 10 year-old patient with tongue lymphangioma who was previously treated with surgery and propranolol with no response was treated with sirolimus in our department. We used sirolimus with a dose of 1.6 mg/m(2)/day. After 3 months of treatment, the mass had decreased by more than 60%. We continued the treatment for 1 year with a maximum response of 70% decrease in mass. Disease remained stable 6 months after stopping therapy, the latest time of follow-up. Sirolimus appears to be effective in lymphangioma but requires further study.
12
Sirolimus for the treatment of complicated vascular anomalies in children
Adrienne M. Hammill, MarySue Wentzel, Anita Gupta et al. · Pediatric Blood & Cancer · 2011 · 618 citations · Full text
Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis
Stephan Huber, Christiane J. Bruns, G. Schmid et al. · Kidney International · 2007 · 205 citations · Full text